GeneDx Holdings Corp [WGS] stock prices are up 7.00% to $63.61 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WGS shares have gain 12.86% over the last week, with a monthly amount drifted -37.77%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on May 15, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $88. Previously, Jefferies upgraded its rating to Buy on May 09, 2025, and kept the price target unchanged to $80. On August 28, 2024, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $34 on the stock. Craig Hallum started tracking the stock assigning a Buy rating and suggested a price target of $43 on July 10, 2024.
The stock price of GeneDx Holdings Corp [WGS] has been fluctuating between $19.16 and $117.75 over the past year. Currently, Wall Street analysts expect the stock to reach $42.5 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $63.61 at the most recent close of the market. An investor can expect a potential drop of -33.19% based on the average WGS price forecast.
Analyzing the WGS fundamentals
The GeneDx Holdings Corp [NASDAQ:WGS] reported sales of 330.14M for trailing twelve months, representing a surge of 39.56%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.17 and Total Capital is -0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 59.74 points at the first support level, and at 55.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 66.01, and for the 2nd resistance point, it is at 68.42.
Ratios To Look Out For
It’s worth pointing out that GeneDx Holdings Corp [NASDAQ:WGS]’s Current Ratio is 3.25. Also, the Quick Ratio is 3.07, while the Cash Ratio stands at 1.43. Considering the valuation of this stock, the price to sales ratio is 5.50, the price to book ratio is 7.05.
Transactions by insiders
Recent insider trading involved Meister Keith A., Director, that happened on May 08 ’25 when 100000.0 shares were purchased. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Apr 29 ’25 to sell 388.0 shares. Meanwhile, Chief Executive Officer Stueland Katherine sold 2154.0 shares on Apr 29 ’25.
